A Phase 3 Trial of Azacitidine Versus a Semi-Intensive Fludarabine and Cytarabine Schedule in Older Patients with Untreated Acute Myeloid Leukemia.
Susana Vives,David Martinez-Cuadron,Juan Bergua Burgues,Lorenzo Algarra,Mar Tormo,Maria Pilar Martinez-Sanchez,Josefina Serrano,Pilar Herrera,Fernando Ramos,Olga Salamero,Esperanza Lavilla,Jose L. Lopez-Lorenzo,Cristina Gil,Belen Vidriales,Jose F. Falantes,Alfons Serrano,Jorge Labrador,Maria J. Sayas,Maria A. Foncillas,Maria L. Amador Barciela,Maria Teresa Olave,Mercedes Colorado,Adriana Gascon, Maria a. Fernandez,Adriana Simiele,Manuel M. Perez-Encinas,Rebeca Rodriguez-Veiga,Olga Garcia,Joaquin Martinez-Lopez,Eva Barragan,Bruno Paiva,Miguel A. Sanz,Pau Montesinos Cancer（2021）
Key words
acute myeloid leukemia,azacitidine,cytarabine,elderly patients,fludarabine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper